NasdaqGS:LVGO

Stock Analysis Report

Executive Summary

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America.

Snowflake

Fundamentals

Adequate balance sheet with limited growth.


Similar Companies

Share Price & News

How has Livongo Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.1%

LVGO

-2.1%

US Healthcare Services

0.07%

US Market


1 Year Return

n/a

LVGO

18.1%

US Healthcare Services

8.9%

US Market

Return vs Industry: Insufficient data to determine how LVGO performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how LVGO performed against the US Market.


Shareholder returns

LVGOIndustryMarket
7 Day3.1%-2.1%0.07%
30 Day-6.8%-5.4%-0.3%
90 Day-45.0%-10.1%-1.6%
1 Yearn/a18.3%18.1%11.3%8.9%
3 Yearn/a65.0%64.5%46.3%36.8%
5 Yearn/a60.9%59.6%62.1%44.3%

Price Volatility Vs. Market

How volatile is Livongo Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Livongo Health undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Livongo Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Livongo Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

Future Growth

How is Livongo Health forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

41.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: LVGO is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: LVGO is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: LVGO is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: LVGO's revenue (44.5% per year) is forecast to grow faster than the US market (7.2% per year).

High Growth Revenue: LVGO's revenue (44.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LVGO is forecast to be unprofitable in 3 years.


Next Steps

Past Performance

How has Livongo Health performed over the past 5 years?

-107.7%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if LVGO's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare LVGO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LVGO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-5.7%).


Return on Equity

High ROE: LVGO has a negative Return on Equity (-40.91%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: LVGO is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: LVGO is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Livongo Health's financial position?


Financial Position Analysis

Short Term Liabilities: LVGO's short term assets ($103.8M) exceeds its short term liabilities ($38.1M)

Long Term Liabilities: LVGO's short term assets (103.8M) exceeds its long term liabilities (11.6M)


Debt to Equity History and Analysis

Debt Level: LVGO is debt free.

Reducing Debt: LVGO has not had any debt for past 5 years.


Balance Sheet

Inventory Level: LVGO has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if LVGO's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LVGO has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: LVGO has less than a year of cash runway if free cash flow continues to reduce at historical rates of -70.2% each year


Next Steps

Dividend

What is Livongo Health's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.0%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate LVGO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate LVGO's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if LVGO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LVGO's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LVGO's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Livongo Health's salary, the management and board of directors tenure and is there insider trading?

1.3yrs

Average management tenure


CEO

Zane Burke (53yo)

0.7yrs

Tenure

0

Mr. Zane M. Burke serves as Chief Executive Officer at Livongo Health, Inc. since February 2019 and serves as its Director since April 2019. Mr. Burke served as the President of Cerner Corporation since Se ...


Management Age and Tenure

1.3yrs

Average Tenure

53yo

Average Age

Experienced Management: LVGO's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Age and Tenure

2.5yrs

Average Tenure

59yo

Average Age

Experienced Board: LVGO's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$74,999,98801 Aug 19
GC Venture LH, LLC
EntityCompany
Shares2,678,571
Max PriceUS$28.00
BuyUS$87,970,26031 Jul 19
Kinnevik AB
EntityCompany
Shares3,141,795
Max PriceUS$28.00

Ownership Breakdown


Management Team

  • Glen Tullman (59yo)

    Founder & Executive Chairman

    • Tenure: 0.7yrs
    • Compensation: US$3.12m
  • Lee Shapiro (63yo)

    Chief Financial Officer

    • Tenure: 0.8yrs
  • Dave Engberg

    Chief Technology Officer

    • Tenure: 3.1yrs
  • Zane Burke (53yo)

    CEO & Director

    • Tenure: 0.7yrs
  • Jim Pursley (39yo)

    Chief Commercial Officer

    • Tenure: 5.5yrs
    • Compensation: US$744.13k
  • Neal Welch

    Vice President of Sales

    • Tenure: 6yrs
  • Jennifer Schneider (44yo)

    President

    • Tenure: 0.8yrs
    • Compensation: US$1.21m
  • Alex Hughes

    VP of Investor Relations

    • Tenure: 0yrs
  • Karl Greiter

    Senior Vice President of Operations

    • Tenure: 1.8yrs
  • Erica Palsis

    General Counsel

    • Tenure: 0.8yrs

Board Members

  • Dave Hartwig (46yo)

    Board Observer

    • Tenure: 3.3yrs
  • Glen Tullman (59yo)

    Founder & Executive Chairman

    • Tenure: 0.7yrs
    • Compensation: US$3.12m
  • Phil Green (68yo)

    Lead Independent Director

    • Tenure: 0yrs
  • Jeff Vinik (59yo)

    Board Observer

    • Tenure: 2.5yrs
  • Karen Daniel (61yo)

    Independent Director

    • Tenure: 0.4yrs
  • Zane Burke (53yo)

    CEO & Director

    • Tenure: 0.7yrs
  • Hemant Taneja

    Independent Director

    • Tenure: 5.5yrs
  • Nagraj Kashyap

    Board Observer

    • Tenure: 2.5yrs
  • Chris Bischoff (46yo)

    Independent Director

    • Tenure: 1.5yrs
  • Tim Anderson

    Board Observer

    • Tenure: 3.3yrs

Company Information

Livongo Health, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Livongo Health, Inc.
  • Ticker: LVGO
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$1.980b
  • Shares outstanding: 94.45m
  • Website: https://www.livongo.com

Number of Employees


Location

  • Livongo Health, Inc.
  • 150 West Evelyn Avenue
  • Suite 150
  • Mountain View
  • California
  • 94041
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LVGONasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDJul 2019

Biography

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuiti ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 00:44
End of Day Share Price2019/10/22 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.